XML 93 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Non-Controlling Interest [Member]
Total
Balance beginning at Dec. 31, 2017 $ 5,323 $ 8,465,294 $ (40,199) $ (3,266,313) $ 83,283 $ 5,247,388
Balance beginning, shares at Dec. 31, 2017 53,233,960          
Common stock sold in public offering, net of offering costs of $956,238 $ 54 2,257,062 2,257,116
Common stock sold in public offering, net of offering costs of $956,238, shares 535,559          
Common stock sold in private placement, net of offering costs of $102,000 $ 91 697,909 698,000
Common stock sold in private placement, net of offering costs of $102,000, shares 906,666          
Fair value of common stock issued in connection with financing transaction 4,640,000 4,640,000
Common stock issued for acquisition of equity method investee $ 4 293,261 293,265
Common stock issued for acquisition of equity method investee, shares 39,102          
Foreign currency translation (26,078) (26,078)
Disposal of noncontrolling interest (26,254) (26,254)
Acquisition of noncontrolling interest   22,666 (51,510) (28,844)
Net Income (loss) for the year       (8,549,767) 224,604 (8,325,163)
Balance ending at Dec. 31, 2018 $ 5,472 16,376,192 (66,277) (11,816,080) 230,123 4,729,430
Balance ending, shares at Dec. 31, 2018 54,715,287          
Fair value of shares issued for acquisition $ 1 41,289 41,290
Fair value of shares issued for acquisition, shares 8,602          
Foreign currency translation (28,892) (28,892)
Disposal of noncontrolling interest (38,509) (38,509)
Net Income (loss) for the year (1,344,549) (4,929) (1,349,478)
Balance ending at Dec. 31, 2019 $ 5,473 $ 16,417,481 $ (95,169) $ (13,160,629) $ 186,685 $ 3,353,841
Balance ending, shares at Dec. 31, 2019 54,723,889